BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Deals

Neuro-Biotech deal

Neuro-Biotech said it received an unsolicited offer from an undisclosed company to acquire all outstanding shares of the biotech for $0.15 per share, or $99.4...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >